Merck & Co., Inc.

MRKNYSEUSD
114.62 USD
1.73 (1.53%)AT CLOSE (11:59 AM EDT)
114.50
0.12 (0.11%)
POST MARKET (AS OF 08:14 PM EDT)
Post Market
AS OF 08:14 PM EDT
114.50
0.12 (0.11%)
🔴Market: CLOSED
Open?$113.37
High?$115.02
Low?$113.10
Prev. Close?$112.89
Volume?6.8M
Avg. Volume?9.8M
VWAP?$114.21
Rel. Volume?0.70x
Bid / Ask
Bid?$113.40 × 200
Ask?$115.00 × 1.7K
Spread?$1.60
Midpoint?$114.20
Valuation & Ratios
Market Cap?278.0B
Shares Out?2.5B
Float?2.4B
Float %?98.2%
P/E Ratio?15.23
P/B Ratio?5.28
EPS?$7.39
Dividend?2.94%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.30Adequate
Cash Ratio?0.51Adequate
Debt/Equity?0.94Moderate
ValuationFAIRLY VALUED
Score
78/100
P/E?
15.2CHEAP
P/B?
5.28FAIR
P/S?
4.28FAIR
P/FCF?
22.5FAIR
EV/EBITDA?
11.2CHEAP
EV/Sales?
4.81FAIR
Returns & Efficiency
ROE?
34.7%STRONG
ROA?
13.3%STRONG
Cash Flow & Enterprise
FCF?$12.4B
Enterprise Value?$312.8B
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75.0K
Market Cap
278.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000